Global Biotechnology Congress 2016 (4th in the Series)

May 11th - 14th 2016, Boston, MA, USA

This unique international conference provides a platform for researchers and decision makers in biotechnology to present their latest findings and learn about all the important developments in biotechnology. Many Nobel Laureates and world's renowned experts will participate in the conference.

The conference will cover the translational nature of biotechnological research, with emphasis on both the basic science as well as its applications in industry and academia. Presentations will include major research advances in biotechnology, business development, strategic alliances, partnering trends, product opportunities, growth business models and strategies, licensing and pharmaceutical biotechnology (e.g. vaccines, CNS, cancer, antibodies), medical biotechnology, industrial biotechnology, bioprocess engineering, protein engineering, plant and environmental technologies, transgenic plant and crops, bioremediation, and microbial diversity research.

Throughout the course of the four day conference, you will have the opportunity to both network and hear leaders from the international academic and corporate biotechnology communities.

The conference is organized by Eureka Conference.

Welcome Note

Prof. Ferid Murad
Nobel Laureate
Conference Co-President

The 'Global Biotechnology Congress 2016' would provide eminent scientists the opportunity to present their cutting edge researches in the field of biotechnology and its applications in medicine. A number of Nobel Laureates and leading researchers are expected to participate in this important conference.

Prof. Atta-ur-Rahman, FRS
Conference Co-President

I would like to welcome the participants to GBC. This should be an exciting event since the leading authorities in their respective fields have agreed to present their latest works during the conference. A large number of students will also be participating in it which should be very educational for them.

Conference Tracks

The conference will encompass the following subjects including:

  • Pharmaceutical Biotechnology: Biopharmaceuticals Discovery (CNS, cancer, cardiovascular, endocrine, immune, systems biology); Vaccines; Antibodies; Protein Engineering; Bioinformatics; Clinical Research/Clinical trials.
  • Plant and Environment: Transgenic Plants and Crops; Bioremediation; Microbial Diversity; Bio-monitoring; Photosynthetic Microorganisms; Cyanobacteria and Microalgae; Translational Genomics and Genomics-assisted Breeding.
  • Industrial and Manufacturing: Bio-fuels; Energy Crops (cellulosic ethanol industry); Industrial Enzymes; Bioprocess Engineering and Optimization.
  • Medical Biotechnology: Biopharmaceutical Manufacturing; Diagnostics; Imaging; Pharmacogenomics (personalized medicine); Microarray Technology; Biomarkers; Clinical Research/Clinical trials.
  • Business Development: Strategic Alliances; Partnering Trends; Product Opportunities; Growth; Business Models and Strategies; Licensing; Merger and Acquisitions; Outsourcing; Venture Capital and Financing; Intellectual Property.
  • Regenerative Medicine: Stem Cells; Gene Therapy; Tissue Engineering; Cell Based Therapy; Cell Cultivation; Clinical Research/Clinical trials.
  • Marine Biotechnology: Environment Applications of Marine Biotechnology; Marine Natural Products; Bio products and Bioactive Compounds; Marine Microbiology and Biodiversity; Marine-based Drug Discovery & Development; Genomics and Proteomics of Marine Organisms; Aquatic Microbial Ecology.
  • Food Biotechnology: Food Microbiology; Recombinant DNA Techniques; Indigenous Food Production; Fermentation Processes; GM Foods; Human Nutrition and Metabolism; Food Safety; Current Status and Future Prospects of Food Biotechnology.
  • Bio-Safety and Bioethics: Biosafety Regulations; Intellectual Property Rights; Ethical Issues of Human Genome Project, Organs Transplantation and Stem Cell Research; Handling and Disposal of Hazardous Materials.
  • Nano biotechnology: Disease Diagnosis; Drug Delivery; Biosensors; Nanofabricated Devices; DNA Nano biotechnology; Lipid Nanotechnology; Future prospects of Nanobiotechnology.

Benefits Of Attending

  • Exchange ideas and network with leading biotechnologists and decision makers.
  • Bring together top international biotechnology professionals presenting cutting-edge discoveries, research and opportunities for new biotech business practices and partnerships.
  • Participants can gain direct access to a core audience of biotechnology professionals and decision makers, and have increased visibility through branding and networking at the conference.
  • Obtain a global roundup of Pharmaceutical research capabilities and opportunities.
  • The conference will feature a commercial exhibition and poster sessions.

Who Should Attend

The conference will attract to a targeted group of scientists and senior international decision makers.

Delegates will have a valuable, informative and positive experience.

  • Biotechnologists
  • Pharmaceutical Scientists
  • Food, Environmental and Plant Scientists
  • Clinicians
  • CEOs, CROs, directors and research associates from the biotechnology industry and academia